Skip to main content

TLRY.TO

Stock
Health Care
Drug Manufacturers - Specialty & Generic

Performance overview

TLRY.TO Price
Price Chart

Forward-looking statistics

Beta
1.03
Risk
71.09%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.

Company info

SectorHealth Care
IndustryDrug Manufacturers - Specialty & Generic
Website—
Employees437
Market cap$2.0B

Fundamentals

Enterprise value$851.7M
Revenue$1.1B
Revenue per employee—
Profit margin-114.40%
Debt to equity12.73

Security info

ExchangeToronto Stock Exchange
Type of shareCommon Stock
Earnings per share (EPS)-$1.49
Dividend per share—
Revenue per share$0.98
Avg trading volume (30 day)$1M
Avg trading volume (10 day)$935K
Put-call ratio—

Macro factor sensitivity

Growth+1.5
Credit+6.9
Liquidity-1.9
Inflation-5.4
Commodities+1.0
Interest Rates-1.2

Valuation

Dividend yield0.00%
PEG Ratio0.02
Price to sales0.90
P/E Ratio22.50
Enterprise Value to Revenue0.76
Price to book0.24

Upcoming events

Next earnings dayApril 8, 2025
Next dividend day—
Ex. dividend day—

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free